Skip to content

Advertisement

Open Access

Bibliometric analysis of global scientific activity on umbilical cord mesenchymal stem cells: a swiftly expanding and shifting focus

Contributed equally
Stem Cell Research & Therapy20189:32

https://doi.org/10.1186/s13287-018-0785-5

Published: 7 February 2018

Abstracts

Several studies have focused on umbilical cord-derived mesenchymal stem cells (UC-MSCs) due to their potential therapeutic effects in a cluster of diseases. However, there has been no bibliometric analysis evaluating the evolution in UC-MSC research. Therefore, this study aimed to assess scientific activity regarding UC-MSC research. Publications on UC-MSCs were retrieved from the Science Citation Index-Expanded (SCI-E) of the Web of Science (WoS) from 1975 to 2017. Statistical analyses were performed using Excel, GraphPad Prism 5, and VOSviewer software. Comparative analyses were employed to assess contributions between different countries, institutes, and researchers. With 21.26 citations per paper, 1206 papers cited 25,517 times were included. Mainland China contributed the most with 558 papers, with the most citations (6858 times) and the highest H-index (43). South Korea ranked first for number of papers per million people and per trillion gross domestic product (GDP). Keywords were stratified into two clusters by VOSviewer software: cluster 1, “treatments and effects”; and cluster 2, “characteristics”. The average appearing years (AAY) of keywords in cluster 1 was more recent than that in cluster 2. For promising hotspots, “TNF-α” showed the latest AAY at 2014.09, followed by “migration”, “angiogenesis”, and “apoptosis”. We conclude that the number of publications has been continuously growing dramatically since 2002 and that mainland China and South Korea are the most productive regions. The focus gradually shifts from “characteristics” to “treatments and effects”. Attention should be drawn to the latest hotspots, such as “TNF-α”, “migration”, “angiogenesis”, and “apoptosis”. Furthermore, funding agencies might increase investments in exploring the therapeutic potential of UC-MSCs.

Keywords

BibliometricCitationH-indexUC-MSCHotspots

Background

Mesenchymal stem cells (MSCs) have a significant capacity for self-renewal and differentiation. Activation of MSCs may provide avenues for regenerative medicine due to convenient isolation techniques and immune allorecognition escape [1]. MSCs encompass multipotent cells derived from bone marrow tissue, umbilical cord, and adipose tissue [2]. Comparatively, umbilical cord-derived MSCs (UC-MSCs) are inexhaustible and can be harvested without any invasive medical operations [1]. In addition, UC-MSCs have been shown to have more efficient proliferation with lower immunogenicity than that of bone marrow-derived MSCs [35]. As a result, a growing number of studies have reported that UC-MSCs may be an alternative source of stem cells with promising therapeutic effects [6, 7]. Research evidence proposes that UC-MSCs can potentially be used to improve cardiac regeneration [811], alleviate cutaneous wounds [1, 12, 13], treat various neurological disorders [3, 14, 15], and ameliorate insulin resistance in type 2 diabetes [16].

However, no bibliometric reports assessing the relevant scientific output and research trends regarding UC-MSCs have been performed. Bibliometrics can assess not only the quantity, but also the quality of publications regarding a specific field, issue, institute, or region [17]. To a certain degree, they can provide details on the development processes in a specific field [18] and can systematically estimate the research activity trends. Moreover, bibliometric analysis can provide reference proposals during government policy establishment, particularly for determining funding-orientation guidance. Until now, bibliometric analysis has been employed for estimating the research trends on dozens of fields such as intracranial aneurysms [19], retina regeneration [20], obesity [21], and spinal tuberculosis [22].

This study aimed to estimate the publication pattern of UC-MSCs worldwide. Data were obtained from the Web of Science (WoS). We systematically assessed publication distribution stratified by geography, institutions, funding agencies, journals, and more. Furthermore, we also assessed the frequency of keywords, and then employed bibliometric mapping to describe the development of UC-MSC research.

Materials and methods

Bibliometric data and search strategy

A comprehensive bibliographic retrieval was performed online using the Web of Science (WoS) on 1 July 2017. This was performed on a single day to avoid daily updating bias since the database is still open.

Search keywords were referred to MESH terms from PubMed, and then the search term was used as follows: TI = *UCMSC* OR TI = *UC-MSC* OR (((TI = (umbilical cord) OR TI = (Wharton’s jelly)) AND (TI = (mesenchymal stromal cell*) OR TI = (mesenchymal stem cell*))) AND Language = English. The time period of article publication was from 1 January 1975 to 1 July 2017. For manuscript types, only peer-reviewed articles and reviews were included.

Distributed details such as original countries, institutes, journals, and funding agencies were refined by WoS.

Data collection

The original data download from WoS were firstly imported into Microsoft Excel 2010, and then were verified and then assessed by two independent researchers (XZ and JZ), respectively. Any difference was unified through discussion. Finally, the following bibliometric parameters were extracted: the quantity of papers, the number of citations, and H-index [23] (https://en.wikipedia.org/wiki/H-index).

Given the differences in aggregate economic volume and populations among countries, we calculated the publication number per million people and per trillion gross domestic product (GDP). The latest information on population and GDP was obtained from the World Bank [24] and the Central Intelligence Agency [25].

Statistical methods

The time trend of the number of publications was analyzed using a mathematical fitting curve via GraphPad Prism 5 (GraphPad Software Inc., CA, USA). The logistic growth model \( \mathrm{f}\left(\mathrm{x}\right)=\mathrm{c}/\left[1+\mathrm{a}\times {\mathrm{e}}^{\left(-\mathrm{b}\times \Big(\mathrm{x}-2001\right)}\right] \) was used to model the cumulative volume of documentation due to its good fitness and ability to predict the future trends in the literature [19, 26], where x represents the year and f(x) is the cumulative volume of papers by year. The year 2001 was defined as year zero since publications were recorded starting from 2002. The inflection point of the logistic growth curve is the point in time when the publication growth rate shifted from positive to negative, and was generated by the formula T = 2001 + ln a/b [19].

The java program VOSviewer (Leiden University, Leiden, Netherlands) was used for mapping and clustering of keywords [27]. It portrayed keywords by colors and sizes of the circles [28] according to keyword occurrences in both titles and abstracts. In addition, hotspots are defined as the keywords of popular scientific fields and their frequency was calculated using VOSviewer.

Results

Evaluation of global publications

We retrieved 1630 publications in total and only included 1206 papers in the analysis (Additional file 1). Figure 1b illustrates that the number of global publications per year increased significantly from 2002. Figure 1b also shows the model fitting curves \( \mathrm{f}\left(\mathrm{x}\right)=23523.68/\left[1+695518.94\times {\mathrm{e}}^{\left(-0.33\times \Big(\mathrm{x}-2001\right)}\right] \) of the cumulative number of publications on UC-MSCs. The global inflection point (the point in time when the publication growth rate moved from positive to negative) was calculated to have occurred in 2014.
Figure 1
Fig. 1

Contributive characteristics of UC-MCS research. a The total publications worldwide and the three most productive countries in UC-MCS research. b Model fitting curves of growth trends of accumulated number of publications on UC-MCS worldwide. c The number of publications on UC-MCS research from the top 10 contribution institutes. d The number of publications of the top 10 popular journals on UC-MCS research

In regards to the research strength of countries (Table 1), mainland China (558 papers, 46.27%) was the most productive, followed by South Korea (160 papers, 13.27%) and the United States (136 papers, 11.28%). When adjusted by population, South Korea was on top with 3.14 papers per million people. After the adjustment by GDP, South Korea also ranked the first with 82.94 papers per trillion GDP, followed by Iran with 36.33 papers per trillion GDP.
Table 1

Publications in the 10 most productive countries

Country

N

%

N per million people

N per trillion GDP

H-index

Total citations

Mainland China

558

46.27

0.41

26.23

43

6858

South Korea

160

13.27

3.14

82.94

36

3838

USA

136

11.28

0.42

7.33

34

3949

Iran

53

4.39

0.64

36.33

9

289

India

43

3.57

0.03

4.93

15

684

Italy

42

3.48

0.68

18.91

17

1029

Taiwan

38

3.15

1.62

33.72

19

2841

Germany

37

3.07

0.46

9.30

16

3395

England

35

2.90

0.54

12.55

14

1056

Japan

29

2.40

0.23

5.88

14

711

GDP gross domestic product

Citation frequency and H-index analysis

Based on WoS database analysis, all publications related to UC-MSCs have been cited 25,517 times with 21.26 citations per paper. In addition, the top 100 UC-MSC research papers contributed 14,252 citations (55.85% of 25,517; Additional file 2). When stratified by region, mainland China was cited the most (6858 times) and achieved the highest H-index (43; Table 1).

Distribution of highly contributive institutes, journals, and funding agencies

The top 10 contributive institutes are listed in Fig. 1c. Seoul National University in South Korea contributed the most publications with 48 papers published, followed by the Chinese Academy of Medical Sciences (42 publications), and Medipost Co. Ltd., from South Korea (38 publications). Among the top 10 productive institutions, six of them were from China, and the other four were Korean institutes.

There were 333 articles published in the top 10 journals (28.51% of all publications; Fig. 1d). Cytotherapy ranked the first (55 articles), followed by PLoS One (48 articles) and Stem Cells and Development (44 articles).

The top 10 funding bodies are shown in Table 2, with seven funding agencies based in China. The National Natural Science Foundation of China endorsed 255 studies in this field (ranked first, 21.14%), followed by the Jiangsu Province for Outstanding Sci Tech Innovation Team in China (16 studies, 1.33%) and the China Postdoctoral Science Foundation (16 studies, 1.33%).
Table 2

The top 10 related funding agencies

Funding agency

N

%

National Natural Science Foundation of China

255

21.14%

Jiangsu Province for Outstanding Sci Tech Innovation Team

16

1.33%

China Postdoctoral Science Foundation

16

1.33%

Fundamental Research Funds for the Central Universities

13

1.08%

Natural Science Foundation of Jiangsu Province

12

1.00%

National Institutes of Health (NIH)

12

1.00%

National Research Foundation of Korea (NRF)

12

1.00%

Ministry of Education Science and Technology

11

0.91%

National Basic Research Program of China

10

0.83%

Ministry of Health And Welfare Republic of Korea

9

0.75%

Highly contributive authors on UC-MSC

The 10 most productive authors contributed 256 papers (21.23%) on UC-MSC research. W. Oh from Medipost Co. Ltd., Biomedical Research Institution, South Korea, contributed the most articles with 31 papers, followed by W.R. Xu from the School of Medicine, Jiangsu University, China, and Z.C. Han from the Chinese Academy of Medical Sciences, Peking Union Medical College, China, with 30 publications each (Table 3).
Table 3

The top 10 authors with the most publications related to UC-MSC research

Author

N

Total citations

H-index

Country

Affiliation

Oh W

31

1187

20

South Korea

Medipost Co. Ltd., Biomedical Research Institute

Han ZC

30

1014

15

China

Chinese Academy of Medical Sciences, Peking Union Medical College

Xu WR

30

943

13

China

School of Medicine, Jiangsu University

Choi SJ

27

754

14

South Korea

Medipost Co. Ltd., Biomedical Research Institute

Qian H

26

756

12

China

School of Medicine, Jiangsu University

Yang YS

26

871

17

South Korea

Medipost Co. Ltd., Biomedical Research Institute

Zhang X

22

555

11

China

School of Medicine, Jiangsu University

Zhu W

22

752

12

China

School of Medicine, Jiangsu University

Kang KS

21

441

13

South Korea

Seoul National University, College of Veterinary Medicine

Yan YM

21

665

10

China

School of Medicine, Jiangsu University

UC-MSC umbilical cord-derived mesenchymal stem cell

Characteristics of the top 10 UC-MSC articles

When it came to the top 10 most cited articles, there were 7398 citations (28.99%; Table 4). The study by Kern et al. [29], published in 2006, was the most cited article (1382 times) with an average citation of 115.17 per year. Among the 10 most cited articles, five were published in Stem Cells, two in Experimental Hematology, one in Blood, one in the British Journal of Haematology, and one in Haematologica.
Table 4

The top 10 UC-MSC research papers with the most citation frequency

Title

First author

Journal

Year

Citations

Citation frequency per year

Main conclusion

Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue

Kern

Stem Cells

2006

1382

115.17

They compared MSCs derived from umbilical cord blood, bone marrow, and adipose tissue regarding morphology, the success rate of isolating MSCs, colony frequency, expansion potential, multiple differentiation capacity, and immune phenotype

Isolation of multipotent mesenchymal stem cells from umbilical cord blood

Lee

Blood

2004

819

58.5

They reported a novel method to obtain single cell-derived, clonally expanded MSCs that are of multilineage differentiation potential

Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord

Wang

Stem Cells

2004

665

47.5

UC-MSC express matrix receptors (CD44, CD105) and integrin markers (CD29, CD51), and can differentiate into cardiomyocytes

Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood

Wagner

Experimental Hematology

2005

660

50.77

They provided a foundation for a more reproducible and reliable quality control using genotypic analysis for defining MSCs

Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood

Bieback

Stem Cells

2004

510

36.43

MSC-like cells can be isolated at high efficacy from full-term UC donations; we regard UC as an additional stem cell source for experimental and potentially clinical purposes

Searching for alternative sources of postnatal human mesenchymal stem cells: Candidate MSC-like cells from umbilical cord

Romanov

Stem Cells

2003

505

33.67

UC vasculature contains a high number of MSC-like elements forming colonies of fibroblastoid cells that may be successfully expanded in culture

Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow

Baksh

Stem Cells

2007

457

41.55

They compared HUCPVCs to the “gold standard” bone marrow mesenchymal stromal cells (BMSCs) with respect to their proliferation, differentiation, and transfection capacities

Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not

Wexler

British Journal of Haematology

2003

384

25.6

Adult BM is a reliable source of functional cultured MSCs, but cord blood and peripheral blood stem cell collections are not

Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials

Lu

Haematologica

2006

381

31.75

They established a protocol to isolate abundant MSCs from human umbilical cords with a 100% success rate. The comparative study indicates that UC is an excellent alternative to BM as a source of MSCs for cell therapies.

Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice

Noort

Experimental Hematology

2002

315

19.69

Upon co-transplantation, MSCs, but not irradiated CD34 or B cells, promote engraftment of UCB CD34+ cells in bone marrow, spleen, and blood.

BM bone marrow, HUCPVC human umbilical cord perivascular cell, MSC mesenchymal stem cell, UC umbilical cord, UCB umbilical cord blood

Hotspot analysis

Keywords were extracted from titles and abstracts of 1206 studies and analyzed by VOSviewer software. Keywords appearing more than 100 times were included in the map (Fig. 2 and Additional file 2) and were stratified into two clusters: cluster 1 (treatments and effects; Fig. 2a, left, in red), and cluster 2 (characteristics; Fig. 2a, right, in green). The most frequent keywords in cluster 1 were “effect” (447 times), “treatment” (357 times), and “transplantation” (343 times). In cluster 2, the most frequent keywords were “umbilical cord” (468 times), “marker” (309 times), and “Wharton” (277 times).
Figure 2
Fig. 2

The mapping on keywords of UC-MCS. a The keywords were divided into two clusters: cluster 1, “treatments and effects”; and cluster 2, “characteristics”. In general, the smaller the distance between two terms, the larger the number of co-occurrences of the terms. The size of the circle represents the frequency of the keyword, with a larger circle indicating the keyword appears more frequently. b Based on the average time of appearance, keywords in blue presented earlier than those in yellow and red

Based on the different average appearing year (AAY) of keywords, VOSviewer marked keywords included in the map with different colors (Fig. 2b). Keywords in blue appeared earlier than those in yellow and red. Keywords in the “treatments and effects”-related cluster 1 appeared in more recent years than those in the “characteristics”-related cluster 2. Besides UC-MSC-related keywords, “TNF-α” showed the latest AAY of 2014.09, followed by “migration” with an AAY of 2013.85, “angiogenesis” with an AAY of 2013.78, and “apoptosis” with an AAY of 2013.76 (Additional file 3).

Discussion

In the present study, we found that the number of global publications per year increased dramatically from 2002, and that the global inflection point may have occurred in 2014. A total of 1206 papers on UC-MSC research have been cited 21.26 times per paper. Mainland China was the most productive region accounting for 46.27% of papers published, with the most citations (6858 times) and the highest H-index (43). South Korea ranked the first regarding number of papers per million people and per trillion GDP. Keywords extracted from titles and abstracts were stratified by VOSviewer software into two clusters, the relatively outdated “characteristics” cluster and the relatively new “treatments and effects” cluster. Furthermore, “TNF-α”, “migration”, “angiogenesis”, and “apoptosis” may be the latest, promising research hotspots in this field.

Prior to 2007, global publications on UC-MSC research exhibited a steady growth, whereas from 2008 onwards, a dramatic growth was witnessed. The regression growth model of cumulative amounts showed an inflection point in 2014; however, there is still a possibility that increasing trends go on longer than expected by the proposed model since function and therapeutic application of UC-MSCs might attract more research attention. Moreover, the scientific communities may pay more attention to these latest issues on UC-MSCs.

When it came to analysis by country, China and South Korea were the most productive countries in this field. We found that both China and South Korea had an overwhelmingly higher number of publications that were supported by local funding agencies and from native innovative institutions than that of other countries. In addition, on the list of top 10 researchers, six were from mainland China and the other four were from South Korea. Oh from South Korea as well as Xu and Han from China contributed the most publications and were leaders in this field. As a result, it is theorized that further publications from these regions may still have an ongoing vital role. Additionally, top scholars from the top institutes can be good choices for partnerships and may also have the priority for more investments and grants.

Regarding journals, those listed in Fig. 2d, such as Cytotherapy, Stem Cells and Development, Stem Cell Research & Therapy, Stem Cells International, Stem Cells, and Cell Transplantation, may be the core journals of UC-MSC research publication. Further studies can be guided for submission to these journals. Subsequently, researchers may pay more attention to research published by the aforementioned journals.

Bibliometrics combined with visualized mapping has been recognized as an effective means of assessing scientific research trends regarding a specific field, both quantitatively and systematically [30]; they can also uncover directions of scientific research, as shown previously [22, 31]. In this study, a gradual shift in terms of research focus from “characteristics” to “treatments and effects” was seen, which is in accordance with the rule of the development of the translational medicine; therefore, the scientific community appears to be interested in the therapeutic potential of UC-MSC research at present. For instance, a pilot clinical trial demonstrated that intravenous transfusion of UC-MSCs was safe and well tolerated, effectively alleviates blood glucose, and increases generation of C-peptide levels and regulatory T cells in a subgroup of type 2 diabetes mellitus patients [32]. Subsequently, those funding agencies may increase investments for these kinds of studies. To illustrate the importance of bibliometric studies, we can also find examples of its impacts in other scientific and professional communities, such as in antimicrobial resistance surveillance. Since data from major surveillance studies are not available for the whole scientific community and are limited by time and region, scholars used bibliometrics methods to compare scientometric results with data from the major surveillance network data and found that bibliometrics provided a fast and reliable global overview of a specific antimicrobial resistance [33]. As a result, bibliometric studies may provide meaningful references for research communities.

While investigating the details provided by visualized mapping, an article titled “Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism” in the more recent “treatments or effects” cluster was found to be the most cited article for a total of 251 times at 20.92 citations per year (published in Stem Cells in 2006) [34]. This paper proposed that UC-MSCs can be a potential therapeutic strategy for Parkinson’s disease.

Furthermore, our data show that the latest research hotspots are “TNF-α” [35, 36], “migration” [3741], “angiogenesis” [8, 4248], and “apoptosis” [4952]. Therefore, this infers that scientific breakthroughs regarding these hotspots may be achieved in the near future. Furthermore, it pinpoints promising research directions which is of interest to scientists and funding agencies.

Strengths and limitations

This bibliometric analysis coupled with visualized mapping can provide systematical information on UC-MSC-related research and help readers learn about the evolution of UC-MSC research with relative ease. Furthermore, since publications were assessed based on countries, institutes, and researchers, the analysis can provide relevant information for scientists and funding agencies by highlighting potential cooperative partnerships and providing investment guidance.

However, there are several limitations to this study. First, it may have missed some important research published in other languages since only English papers were retrieved and included in the analysis. Second, all studies could not be identified using one database search. Journals included in the database of Science Citation Index-Expanded (SCI-E) in WoS are described as the world’s leading journals due to a rigorous selection process, and the concept of SCI was based on Bradford’s law in bibliometrics, which can be applied to define a core set of journals or publications. As a result, publications included in WoS may represent studies in the discipline, and WoS provided metadata with further distribution refinement. Third, there exists a discrepancy between bibliometric analysis results and real research conditions; this is due to the database remaining open as it continuously updates studies. Moreover, the increasing trend in the number of papers published might be sustained longer than that calculated by the mathematical model.

Conclusion

The number of publications regarding UC-MSCs has been continuously growing since 2002. Mainland China and South Korea were found to be the most productive regions. Keyword focus gradually shifted from “characteristics” to “treatments and effects”, meaning that those funding agencies may increase investments for exploring the therapeutic potential of UC-MSCs. It is recommended to pay closer attention to the latest promising hotspots, such as “TNF-α”, “migration”, “angiogenesis”, and “apoptosis”.

Abbreviations

AAY: 

Average appearing years

GDP: 

Gross domestic product

MSC: 

Mesenchymal stem cell

SCI-E: 

Science Citation Index-Expanded

UC-MSC: 

Umbilical cord-derived mesenchymal stem cell

WoS: 

Web of Science

Declarations

Acknowledgements

Not applicable.

Availability of data and materials

The dataset supporting the conclusions of this article is included within the article (Additional files 2 and 3).

Funding

This study was supported by the Foundation of Changhai Hospital (CH201717) and the National Natural Science Foundation of China (81701199, 81601953, and 81670741).

Authors’ contributions

XZ and QW: conceived and designed the experiments. GY and XL: performed the experiments. YY: analyzed the data. XZ, JZ, and MC: wrote the paper. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable since the manuscript is entirely original; the tables and figures presented are original for this article and have neither been published nor are currently under consideration for publication by any other journal.

Competing interests

The authors declare that they have no competing interests

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Orthopedics, Changhai Hospital, Second Military Medical University, Shanghai, China
(2)
Graduate Management Unit, Second Military Medical University, Shanghai, China
(3)
Department of Colorectal Surgery, Changhai Hospital, Second Military Medical University, Shanghai, China
(4)
Department of Radiation Medicine, Faculty of Naval Medicine, Second Military Medical University, Shanghai, China
(5)
Department of Endocrinology, Changhai Hospital, Second Military Medical University, Shanghai, China

References

  1. Zhang B, Wang M, Gong A, Zhang X, Wu X, Zhu Y, Shi H, Wu L, Zhu W, Qian H, Xu W. HucMSC-exosome mediated-Wnt4 signaling is required for cutaneous wound healing. Stem Cells. 2015;33:2158–68.View ArticlePubMedGoogle Scholar
  2. Pires AO, Mendes-Pinheiro B, Teixeira FG, Anjo SI, Ribeiro-Samy S, Gomes ED, Serra SC, Silva NA, Manadas B, Sousa N, Salgado AJ. Unveiling the differences of secretome of human bone marrow mesenchymal stem cells, adipose tissue-derived stem cells, and human umbilical cord perivascular cells: a proteomic analysis. Stem Cells Dev. 2016;25:1073–83.View ArticlePubMedGoogle Scholar
  3. Yousefifard M, Nasirinezhad F, Shardi Manaheji H, Janzadeh A, Hosseini M, Keshavarz M. Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model. Stem Cell Res Ther. 2016;7:36.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Mennan C, Brown S, McCarthy H, Mavrogonatou E, Kletsas D, Garcia J, Balain B, Richardson J, Roberts S. Mesenchymal stromal cells derived from whole human umbilical cord exhibit similar properties to those derived from Wharton’s jelly and bone marrow. FEBS Open Bio. 2016;6:1054–66.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Barcia RN, Santos JM, Filipe M, Teixeira M, Martins JP, Almeida J, Agua-Doce A, Almeida SC, Varela A, Pohl S, Dittmar KE, Calado S, Simoes SI, Gaspar MM, Cruz ME, Lindenmaier W, Graca L, Cruz H, Cruz PE. What makes umbilical cord tissue-derived mesenchymal stromal cells superior immunomodulators when compared to bone marrow derived mesenchymal stromal cells? Stem Cells Int. 2015;2015:583984.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Zhang B, Shen L, Shi H, Pan Z, Wu L, Yan Y, Zhang X, Mao F, Qian H, Xu W. Exosomes from human umbilical cord mesenchymal stem cells: identification, purification, and biological characteristics. Stem Cells Int. 2016;2016:1929536.PubMedPubMed CentralGoogle Scholar
  7. Klontzas ME, Vernardis SI, Heliotis M, Tsiridis E, Mantalaris A. Metabolomics analysis of the osteogenic differentiation of umbilical cord blood mesenchymal stem cells reveals differential sensitivity to osteogenic agents. Stem Cells Dev. 2017;26:723–33.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Ma J, Zhao Y, Sun L, Sun X, Zhao X, Sun X, Qian H, Xu W, Zhu W. Exosomes derived from Akt-modified human umbilical cord mesenchymal stem cells improve cardiac regeneration and promote angiogenesis via activating platelet-derived growth factor D. Stem Cells Transl Med. 2017;6:51–9.View ArticlePubMedGoogle Scholar
  9. Mao C, Hou X, Wang B, Chi J, Jiang Y, Zhang C, Li Z. Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats. Stem Cell Res Ther. 2017;8:18.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Lian J, Lv S, Liu C, Liu Y, Wang S, Guo X, Nan F, Yu H, He X, Sun G, Ma X. Effects of serial passage on the characteristics and cardiac and neural differentiation of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells. Stem Cells Int. 2016;2016:9291013.View ArticlePubMedGoogle Scholar
  11. Zhao Y, Sun X, Cao W, Ma J, Sun L, Qian H, Zhu W, Xu W. Exosomes derived from human umbilical cord mesenchymal stem cells relieve acute myocardial ischemic injury. Stem Cells Int. 2015;2015:761643.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Zhang B, Shi Y, Gong A, Pan Z, Shi H, Yang H, Fu H, Yan Y, Zhang X, Wang M, Zhu W, Qian H, Xu W. HucMSC exosome-delivered 14-3-3zeta orchestrates self-control of the Wnt response via modulation of YAP during cutaneous regeneration. Stem Cells. 2016;34:2485–500.View ArticlePubMedGoogle Scholar
  13. Moon KC, Lee JS, Han SK, Lee HW, Dhong ES. Effects of human umbilical cord blood-derived mesenchymal stromal cells and dermal fibroblasts on diabetic wound healing. Cytotherapy. 2017;19:821–8.View ArticlePubMedGoogle Scholar
  14. Mueller M, Oppliger B, Joerger-Messerli M, Reinhart U, Barnea E, Paidas M, Kramer BW, Surbek DV, Schoeberlein A. Wharton’s jelly mesenchymal stem cells protect the immature brain in rats and modulate cell fate. Stem Cells Dev. 2017;26:239–48.View ArticlePubMedGoogle Scholar
  15. Oppliger B, Joerger-Messerli M, Mueller M, Reinhart U, Schneider P, Surbek DV, Schoeberlein A. Intranasal delivery of umbilical cord-derived mesenchymal stem cells preserves myelination in perinatal brain damage. Stem Cells Dev. 2016;25:1234–42.View ArticlePubMedGoogle Scholar
  16. Xie Z, Hao H, Tong C, Cheng Y, Liu J, Pang Y, Si Y, Guo Y, Zang L, Mu Y, Han W. Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats. Stem Cells. 2016;34:627–39.View ArticlePubMedGoogle Scholar
  17. Ekinci S, Agilli M, Ersen O, Ekinci GH. Letter to the Editor regarding Analysis of changing paradigms of management in 179 patients with spinal tuberculosis during a 12-year period and proposal of a new management algorithm. World Neurosurg. 2015;84:2072.View ArticlePubMedGoogle Scholar
  18. Avcu G, Sahbudak Bal Z, Duyu M, Akkus E, Karapinar B, Vardar F. Thanks to trauma: a delayed diagnosis of Pott disease. Pediatr Emerg Care. 2015;31:e17–8.View ArticlePubMedGoogle Scholar
  19. Jia ZJ, Hong B, Chen DM, Huang QH, Yang ZG, Yin C, Deng XQ, Liu JM. China’s growing contribution to global intracranial aneurysm research (1991–2012): a bibliometric study. PLoS One. 2014;9:e91594.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Cislo-Pakuluk A, Marycz K. A promising tool in retina regeneration: current perspectives and challenges when using mesenchymal progenitor stem cells in veterinary and human ophthalmological applications. Stem Cell Rev. 2017;13:598–602.View ArticlePubMedPubMed CentralGoogle Scholar
  21. Khan A, Choudhury N, Uddin S, Hossain L, Baur LA. Longitudinal trends in global obesity research and collaboration: a review using bibliometric metadata. Obes Rev. 2016;17:377–85.View ArticlePubMedGoogle Scholar
  22. Wang Y, Wang Q, Zhu R, Yang C, Chen Z, Bai Y, Li M, Zhai X. Trends of spinal tuberculosis research (1994–2015): a bibliometric study. Medicine (Baltimore). 2016;95:e4923.View ArticleGoogle Scholar
  23. Sweileh WM. Bibliometric analysis of literature on toxic epidermal necrolysis and Stevens-Johnson syndrome: 1940–2015. Orphanet J Rare Dis. 2017;12:14.View ArticlePubMedPubMed CentralGoogle Scholar
  24. World Bank Data Development. http://databank.worldbank.org/data/reports.aspx?Code=NY.GDP.MKTP.CD&id=1ff4a498&report%5Fname=Popular-Indicators&populartype=series&ispopular=y#. Accessed 12 Jan 2018.
  25. Central Intelligence Agency. https://www.cia.gov/library/publications/the-world-factbook/. Accessed 12 Jan 2018.
  26. Bagley SC, White H, Golomb BA. Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain. J Clin Epidemiol. 2001;54:979–85.View ArticlePubMedGoogle Scholar
  27. Synnestvedt MB, Chen C, Holmes JH. CiteSpace II: visualization and knowledge discovery in bibliographic databases. AMIA… Annual Symposium proceedings/AMIA Symposium. AMIA Symposium; 2005:724–8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1560567/.
  28. Khalil GM, Gotway Crawford CA. A bibliometric analysis of U.S.-based research on the Behavioral Risk Factor Surveillance System. Am J Prev Med. 2015;48:50–7.View ArticlePubMedGoogle Scholar
  29. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24:1294–301.View ArticlePubMedGoogle Scholar
  30. Tijssen RJ, Winnink J. Twenty-first century macro-trends in the institutional fabric of science: bibliometric monitoring and analysis. Scientometrics. 2016;109:2181–94.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Jin Y, Cui Z, Li X, Jin X, Peng J. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer. Oncotarget. 2017;8:26090–9.PubMedPubMed CentralGoogle Scholar
  32. Kong D, Zhuang X, Wang D, Qu H, Jiang Y, Li X, Wu W, Xiao J, Liu X, Liu J, Li A, Wang J, Dou A, Wang Y, Sun J, Lv H, Zhang G, Zhang X, Chen S, Ni Y, Zheng C. Umbilical cord mesenchymal stem cell transfusion ameliorated hyperglycemia in patients with type 2 diabetes mellitus. Clin Lab. 2014;60:1969–76.View ArticlePubMedGoogle Scholar
  33. Brandt C, Makarewicz O, Fischer T, Stein C, Pfeifer Y, Werner G, Pletz MW. The bigger picture: the history of antibiotics and antimicrobial resistance displayed by scientometric data. Int J Antimicrob Agents. 2014;44:424–30.View ArticlePubMedGoogle Scholar
  34. Fu YS, Cheng YC, Lin MY, Cheng H, Chu PM, Chou SC, Shih YH, Ko MH, Sung MS. Conversion of human umbilical cord mesenchymal stem cells in Wharton’s jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells. 2006;24:115–24.View ArticlePubMedGoogle Scholar
  35. Sun Y, Kong W, Huang S, Shi B, Zhang H, Chen W, Zhang H, Zhao C, Tang X, Yao G, Feng X, Sun L. Comparable therapeutic potential of umbilical cord mesenchymal stem cells in collagen-induced arthritis to TNF inhibitor or anti-CD20 treatment. Clin Exp Rheumatol. 2017;35:288–95.PubMedGoogle Scholar
  36. Li X, Du W, Ma FX, Feng X, Bayard F, Han ZC. High concentrations of TNF-alpha induce cell death during interactions between human umbilical cord mesenchymal stem cells and peripheral blood mononuclear cells. PLoS One. 2015;10:e0128647.View ArticlePubMedPubMed CentralGoogle Scholar
  37. Arora S, Saha S, Roy S, Das M, Jana SS, Ta M. Role of nonmuscle myosin II in migration of Wharton’s jelly-derived mesenchymal stem cells. Stem Cells Dev. 2015;24:2065–77.View ArticlePubMedPubMed CentralGoogle Scholar
  38. Himal I, Goyal U, Ta M. Evaluating Wharton’s jelly-derived mesenchymal stem cell’s survival, migration, and expression of wound repair markers under conditions of ischemia-like stress. Stem Cells Int. 2017;2017:5259849.View ArticlePubMedPubMed CentralGoogle Scholar
  39. Huang C, Zhao L, Gu J, Nie D, Chen Y, Zuo H, Huan W, Shi J, Chen J, Shi W. The migration and differentiation of hUC-MSCs(CXCR4/GFP) encapsulated in BDNF/chitosan scaffolds for brain tissue engineering. Biomed Mater. 2016;11:035004.View ArticlePubMedGoogle Scholar
  40. Shen C, Lie P, Miao T, Yu M, Lu Q, Feng T, Li J, Zu T, Liu X, Li H. Conditioned medium from umbilical cord mesenchymal stem cells induces migration and angiogenesis. Mol Med Rep. 2015;12:20–30.View ArticlePubMedPubMed CentralGoogle Scholar
  41. Huang L, Niu C, Willard B, Zhao W, Liu L, He W, Wu T, Yang S, Feng S, Mu Y, Zheng L, Li K. Proteomic analysis of porcine mesenchymal stem cells derived from bone marrow and umbilical cord: implication of the proteins involved in the higher migration capability of bone marrow mesenchymal stem cells. Stem Cell Res Ther. 2015;6:77.View ArticlePubMedPubMed CentralGoogle Scholar
  42. Liu J, Hao H, Xia L, Ti D, Huang H, Dong L, Tong C, Hou Q, Zhao Y, Liu H, Fu X, Han W. Hypoxia pretreatment of bone marrow mesenchymal stem cells facilitates angiogenesis by improving the function of endothelial cells in diabetic rats with lower ischemia. PLoS One. 2015;10:e0126715.View ArticlePubMedPubMed CentralGoogle Scholar
  43. Zhang B, Wu X, Zhang X, Sun Y, Yan Y, Shi H, Zhu Y, Wu L, Pan Z, Zhu W, Qian H, Xu W. Human umbilical cord mesenchymal stem cell exosomes enhance angiogenesis through the Wnt4/beta-catenin pathway. Stem Cells Transl Med. 2015;4:513–22.View ArticlePubMedPubMed CentralGoogle Scholar
  44. Todeschi MR, El Backly R, Capelli C, Daga A, Patrone E, Introna M, Cancedda R, Mastrogiacomo M. Transplanted umbilical cord mesenchymal stem cells modify the in vivo microenvironment enhancing angiogenesis and leading to bone regeneration. Stem Cells Dev. 2015;24:1570–81.View ArticlePubMedPubMed CentralGoogle Scholar
  45. Kuchroo P, Dave V, Vijayan A, Viswanathan C, Ghosh D. Paracrine factors secreted by umbilical cord-derived mesenchymal stem cells induce angiogenesis in vitro by a VEGF-independent pathway. Stem Cells Dev. 2015;24:437–50.View ArticlePubMedGoogle Scholar
  46. Arutyunyan I, Fatkhudinov T, Kananykhina E, Usman N, Elchaninov A, Makarov A, Bolshakova G, Goldshtein D, Sukhikh G. Role of VEGF-A in angiogenesis promoted by umbilical cord-derived mesenchymal stromal/stem cells: in vitro study. Stem Cell Res Ther. 2016;7:46.View ArticlePubMedPubMed CentralGoogle Scholar
  47. Pereira AR, Mendes TF, Ministro A, Teixeira M, Filipe M, Santos JM, Barcia RN, Goyri-O’Neill J, Pinto F, Cruz PE, Cruz HJ, Santos SC. Therapeutic angiogenesis induced by human umbilical cord tissue-derived mesenchymal stromal cells in a murine model of hindlimb ischemia. Stem Cell Res Ther. 2016;7:145.View ArticlePubMedPubMed CentralGoogle Scholar
  48. Yin C, Liang Y, Zhang J, Ruan G, Li Z, Pang R, Pan X. Umbilical cord-derived mesenchymal stem cells relieve hindlimb ischemia through enhancing angiogenesis in tree shrews. Stem Cells Int. 2016;2016:9742034.View ArticlePubMedPubMed CentralGoogle Scholar
  49. Li X, Xu Z, Bai J, Yang S, Zhao S, Zhang Y, Chen X, Wang Y. Umbilical cord tissue-derived mesenchymal stem cells induce T lymphocyte apoptosis and cell cycle arrest by expression of indoleamine 2, 3-dioxygenase. Stem Cells Int. 2016;2016:7495135.PubMedPubMed CentralGoogle Scholar
  50. Tang YM, Bao WM, Yang JH, Ma LK, Yang J, Xu Y, Yang LH, Sha F, Xu ZY, Wu HM, Zhou W, Li Y, Li YH. Umbilical cord-derived mesenchymal stem cells inhibit growth and promote apoptosis of HepG2 cells. Mol Med Rep. 2016;14:2717–24.View ArticlePubMedGoogle Scholar
  51. Wang GH, Liu Y, Wu XB, Lu Y, Liu J, Qin YR, Li T, Duan HF. Neuroprotective effects of human umbilical cord-derived mesenchymal stromal cells combined with nimodipine against radiation-induced brain injury through inhibition of apoptosis. Cytotherapy. 2016;18:53–64.View ArticlePubMedGoogle Scholar
  52. Dzobo K, Vogelsang M, Thomford NE, Dandara C, Kallmeyer K, Pepper MS, Parker MI. Wharton’s jelly-derived mesenchymal stromal cells and fibroblast-derived extracellular matrix synergistically activate apoptosis in a p21-dependent mechanism in WHCO1 and MDA MB 231 cancer cells in vitro. Stem Cells Int. 2016;2016:4842134.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement